Logo do repositório
 
Publicação

HIV-1 antiretroviral drug resistance in Mozambique : a systematic review and meta-analysis

datacite.subject.fosCiências Médicas::Ciências da Saúde
datacite.subject.sdg03:Saúde de Qualidade
dc.contributor.authorGonçalves, Paloma
dc.contributor.authorMascarenhas, Paulo
dc.contributor.authorMarcelino, Rute
dc.contributor.authorMabunda, Nédio
dc.contributor.authorKroidl, Arne
dc.contributor.authorBuck, W. Chris
dc.contributor.authorJani, Ilesh
dc.contributor.authorPalladino, Claudia
dc.contributor.authorTaveira, Nuno
dc.date.accessioned2026-04-02T08:11:50Z
dc.date.available2026-04-02T08:11:50Z
dc.date.issued2024-12
dc.description.abstractThis systematic review assessed the prevalence of transmitted and acquired HIV drug resistance (HIVDR) and the associated risk factors in Mozambique. A search of the PubMed, Cochrane, B-On, and Scopus databases up to December 2023 was conducted and included 11 studies with 1118 HIV-1 pol sequences. Drug resistance mutations (DRMs) to NNRTIs were found in 13% of the drug-naive individuals and 31% of those on ART, while NRTI resistance occurred in 5% and 10%, respectively. Dual-class resistance (NNRTI + NRTI) was detected in 2% of the drug-naive and 8% of ART-experienced individuals. DRMs to protease inhibitors (PIs) were found in 2% of the drug-naive and 5% of ART-experienced individuals. The rate of DRMs was significantly higher in Beira than in Maputo, as well as in pediatric patients than in adults and pregnant women. Subtype C predominated (94%) and was associated with lower viral loads and DRM rates as compared to the other subtypes. The high prevalence of DRMs, particularly to NNRTIs and NRTIs, highlights the need for ongoing surveillance and targeted interventions. These findings are critical for optimizing ART regimens and informing public health strategies in Mozambique, with particular attention to regions such as Beira and vulnerable populations such as pediatric patients.eng
dc.identifier.citationGonçalves P, Mascarenhas P, Marcelino R, Mabunda N, Kroidl A, Buck WC, Jani I, Palladino C, Taveira N. HIV-1 Antiretroviral Drug Resistance in Mozambique: A Systematic Review and Meta-Analysis. Viruses. 2024; 16(12):1808. https://doi.org/10.3390/v16121808
dc.identifier.doi10.3390/v16121808
dc.identifier.issn1999-4915
dc.identifier.urihttp://hdl.handle.net/10400.26/62578
dc.language.isoeng
dc.peerreviewedyes
dc.publisherMDPI
dc.relation.hasversionhttps://doi.org/10.3390/v16121808
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectHIV drug resistance (HIVDR)
dc.subjectantiretroviral therapy (ART)
dc.subjectMozambique
dc.subjectdrug resistance mutations (DRMs)
dc.subjectsystematic review and meta-analysis
dc.titleHIV-1 antiretroviral drug resistance in Mozambique : a systematic review and meta-analysiseng
dc.typecontribution to journal
dspace.entity.typePublication
oaire.citation.issue12
oaire.citation.startPage1808
oaire.citation.titleViruses
oaire.citation.volume16
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
Artigo_NTaveira_2024_08.pdf
Tamanho:
1.3 MB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.85 KB
Formato:
Item-specific license agreed upon to submission
Descrição: